Lyons SA, M C, AC K, Ballmer-Weber BK, M F-R, L B, Bieli C, R D, Fernandez-Perez C, Jedrzejczak-Czechowicz M, et al. Prevalence of Food Sensitization and Food Allergy in Children across Europe. J Allergy Clin Immunol Pract. [Internet]. 2020.
Publisher's Version Klimek L, M J, Akdis C, J B, Akdis M, C B, I A, Ansotegui I, Bedbrook A, Bosnic-Anticevich S, et al. ARIA-MASK study group. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy 2020 [Internet]. 2020.
Publisher's VersionAbstract
Taka S, Tzani-Tzanopoulou P, Wanstall H, NG P.
MicroRNAs in Asthma and Respiratory Infections: Identifying Common Pathways. Allergy Asthma Immunol Res 2020. 2020;12(1):4-23.
Kraft M, Knop MP, Renaudin JM, Scherer Hofmeier K, Pföhler C, Bilò MB, Lang R, Treudler R, Wagner N, Spindler T, et al. Network for Online Registration of Anaphylaxis (NORA). Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry. Allergy 2020. 2020;75(4):901-910.
Hoffmann TM, Acar Şahin A, Aggelidis X, Arasi S, Barbalace A, Bourgoin A, Bregu B, Brighetti MA, Caeiro E, Caglayan Sozmen S, et al. "Whole" vs. "Fragmented" approach to EAACI Pollen Season Definitions: A Multicenter Study in Six Southern European Cities. Allergy 2020. 2020;75(7):1659-1671.
GW C, Alacqua M, Altraja A, Backer V, Bel E, Bjermer L, Bjornsdottir US, Bourdin A, Brusselle GG, Christoff GC, et al. International Severe Asthma Registry: Mission Statement. Chest 2020. 2020;157(4):805-814.
Grimshaw KEC, Roberts G, Selby A, Reich A, Butiene I, M C, R D, Fiandor A, Fiocchi A, Grabenhenrich LB, et al. Risk Factors for Hen's Egg Allergy in Europe: EuroPrevall Birth Cohort. J Allergy Clin Immunol Pract 2020. 2020;8(4):1341-1348.
P X, Korovessi P, C B, S F, Jartti T, Lakoumentas J, L KM, Lewandowska-Polak A, Lukkarinen H, Zhang N, et al. Evolution of Airway Inflammation in Preschoolers with Asthma-Results of a Two-Year Longitudinal Study. J Clin Med 2020. 2020;9(9):1.
Abstract
Bédard A, Antó JM, JA F, Arnavielhe S, C B, Bedbrook A, C B-J, Bosnic-Anticevich S, Cardona V, AA C, et al. MASK study group. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air® App. Allergy 2020. 2020;75(7):1672-1688.
Abstract
Adamiec A, Ambrożej D, Ryczaj K, Ruszczynski M, Elenius V, Cavkaytar O, G H, Konradsen JR, P M, Makrinioti H, et al. EAACI Task Force on Clinical Practice Recommendations on Preschool Wheeze. Preschool wheezing diagnosis and management-Survey of physicians' and caregivers' perspective. Pediatr Allergy Immunol 2020. 2020;31(2):206-209.
Mitsias DI, Dimou MV, Lakoumentas J, Alevizopoulos K, Sousa-Pinto B, JA F, J B, NG P.
Effect of nasal irrigation on allergic rhinitis control in children; complementarity between CARAT and MASK outcomes. Clin Transl Allergy 2020. 2020;13(10):9.
Levin M, Morais-Almeida M, Ansotegui IJ, Bernstein J, Chang YS, Chikhladze M, Ebisawa M, Fiocchi A, Heffler E, Martin B, et al. Acute asthma management during SARS-CoV2-pandemic 2020. World Allergy Organ J 2020. 2020;14.
Abstract
Kölle J, Haag P, Vuorinen T, Alexander K, Rauh M, Zimmermann T, NG P, S F.
Respiratory infections regulated blood cells IFN-β-PD-L1 pathway in pediatric asthma. Immun Inflamm Dis 2020, [Internet]. 2020.
Publisher's Version NA K, Zafiriou E, P X, Taka S, NG P, Roussaki-Schulze AV.
Autologous Whole-blood Injections in Chronic Spontaneous Urticaria: Assessment of Efficacy Biomarkers. Iran J Allergy Asthma Immunol 2020. 2020;19(2):206-208.
Abstract
Lyons SA, AC K, PGJ B, Fernández-Rivas M, Ballmer-Weber BK, L B, Bieli C, M C, R D, Fernández-Perez C, et al. Predictors of Food Sensitization in Children and Adults across Europe. J Allergy Clin Immunol Pract 2020, [Internet]. 2020.
Publisher's Version M H, Bourdin A, NG P, ST H, Hanania NA, Halpin DMG, Chapman KR, Gavornikova M, Price DB, Kaplan A, et al. Reducing the hidden burden of severe asthma: recognition and referrals from primary practice. J Asthma 2020. 2020;13(1):6.
Abstract
J B, M J, CA A, Klimek L, Pfaar O, Nadeau KC, Eiwegger T, Bedbrook A, Ansotegui IJ, JM A, et al. ARIA‐EAACI statement on Asthma and COVID‐19. Allergy [Internet]. 2020.
Publisher's Version Tanno L, Chalmers R, Jacob R, Kostanjsek N, Bierrenbach A, Martin B, Molinari N, Annesi-Maesano I, NG P, Sanchez-Borges M, et al. Global implementation of the world health organization's International Classification of Diseases (ICD)-11: The allergic and hypersensitivity conditions model. Allergy [Internet]. 2020.
Publisher's Version Pfaar Ο, Klimek L, M, Jutel, CA A, J B, Breiteneder H, Chinthrajah S, Diamant Z, Eiwegger T, WJ F, et al. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper. Allergy [Internet]. 2020.
Publisher's Version J B, Josep AM, Claus B, Tari H, Torsten Z, Wienczyslawa C, Bedbrook A, Bosnic-Anticevich S, Walter C, Cardona V, et al. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice. Allergy [Internet]. 2020.
Publisher's Version I A, Akdis C, Akdis M, Walter Canonica G, Casale T, Chivato T, Corren J, Chu D, Del Giacco S, Eiwegger T, et al. EAACI Biologicals Guidelines - Recommendations for severe asthma. Allergy [Internet]. 2020.
Publisher's Version Nelson P, NG P, Skevaki C.
Respiratory Viral Pathogens. Reference Module in Biomedical Sciences [Internet]. 2020.
Publisher's Version J B, JM A, Laccarino G, Czarlewski W, T H, Anto A, CA A, Blain H, GW C, Cardona V, et al. Is diet partly responsible for differences in COVID-19 death rates between and within countries?. Clin Transl Allergy. 2020;10(16).
I A, Rocha C, Beltran J, Song Y, Posso M, Solà I, Alonso-Coello P, Akdis C, Akdis M, GW C, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020;75(5):1023-1042.
I A, Rocha C, Beltran J, Song Y, Posso M, Solà I, Alonso-Coello P, Akdis C, Akdis M, GW C, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020;75(5):1043-1057.
Niespodziana K, Borochova K, Pazderova P, Schlederer T, Astafyeva Τ, Baranovskaya T, Barbouche MR, Beltyukov E, Berger A, Borzova E, et al. Toward personalization of asthma treatment according to trigger factors. Allergy Clin Immunol J. 2020;145(6):1529-1534.